Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain ...

Researchers looked specifically at head-to-head randomized clinical trials of next-in-class cancer drugs against existing agents in the same class. Less than one-quarter of next-in-class cancer drugs ...

The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered ...

Terri Bagley spent nearly two decades searching for a way to get a good night’s sleep. She toyed with keeping her bedroom pitch black and sniffing in the soothing smell of lavender. But neither those ...

In 22.2% of trials, there was a survival benefit with the next-in-class agent. Less than one-quarter of next-in-class cancer drugs demonstrated a survival benefit over existing in-class agents in head ...